Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Double-blind, Placebo-controlled Randomised Study on the Efficacy of Naloxone Nasal Spray for the Treatment of Gambling Disorder

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03430180
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:13.739865+00:00
Published At
2019-07-16T00:00:00+00:00
Record Updated At
2019-07-16
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Pathological Gambling", "Gambling Disorder", "Opioid Antagonist", "Naloxone"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-07-16"
protocolSection.identificationModule.nctId
"NCT03430180"
protocolSection.identificationModule.officialTitle
"Double-blind, Placebo-controlled Randomised Study on the Efficacy of Naloxone Nasal Spray for the Treatment of Gambling Disorder"
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Pathological Gambling (protocolSection.conditionsModule.conditions)
  • Gambling Disorder (protocolSection.conditionsModule.conditions)
  • Opioid Antagonist (protocolSection.conditionsModule.conditions)
  • Naloxone (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.